Analysts think these two discount retailers could benefit from the new tariff regime.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) announced better-than-expected revenue in Q4 CY2025, with sales up 29.6% year on year to $247.1 million. The company’s full-year revenue guidance of $1.09 billion at the midpoint came in 4

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Blackstone has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.

AppLovin has outperformed the Nasdaq over the past year, and analysts are highly optimistic about the stock’s prospects.

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like

Southern Company has underperformed the S&P 500 over the past year, and analysts are cautious about the stock’s prospects.

HCA Healthcare has outperformed the Healthcare Providers industry over the past year, and analysts are moderately optimistic about the stock’s prospects.

Starbucks has underperformed the Consumer Discretionary sector over the past year, but analysts are moderately optimistic about the stock’s prospects.

U.S. stock index futures slid on Friday as growing AI unease weighed on technology stocks, with the Nasdaq staring at its steepest monthly drop since March 2025, ‌and investors awaited key inflation data later in the day. Technology stocks saw immense tur

Children’s apparel manufacturer Carter’s (NYSE:CRI) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 7.6% year on year to $925.5 million. Its non-GAAP profit of $1.90 per share was 11.5% above analysts’ consensus estimates.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Nasdaq (NASDAQ:NDAQ) and the best and worst performers in the financial exchanges & data industry.

As Airbnb has outperformed its industry peers over the past year, Wall Street analysts maintain a cautiously upbeat outlook on the stock’s prospect.

Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 11.5% year on year to $814.3 million. On the other hand, the company’s full-year revenue guidance of $3.1 billi